forum

AUROPHARMA Share Price Discussion

Aurobindo Pharma Ltd.
Sector: Pharmaceuticals and health care
... Read more
AUROPHARMA Share Price *
455.15 -4.1 (-0.89%)
* (quote may be delayed)

AUROPHARMA Discussion Forum


Sell auro pharma cash
453.5-455.5
Sl 457
Tgt 450/447
Like
reply
Reply (2)
share
Share
Latest replies

455 to 452

Look at auropharma guys
455 to 450.4
New day low 450.4
5 points in few times
tgt 1dn - 450
💸💸💸💸💸enjoy
Aurobindo Pharma breaks 2-day losing run; jumps 5%
The stock has been moving in the range of Rs 700-835 for a year. Once the stock breached the lower level of range at Rs 700, it gave a sharp correction of 260 points in the span of five-month to make five year low of Rs 435.
Moneycontrol
Like
reply
Reply
share
Share
Aurobindo Q2 PAT seen up 6% YoY to Rs. 675.1 cr: Emkay
Net Sales are expected to increase by 18.8 percent Y-o-Y (up 3.7 percent Q-o-Q) to Rs. 5,645.7 crore, according to Emkay.
Moneycontrol
Like
reply
Reply
share
Share

AUROPHARMA - 397375
This is the proof of trade of 480 ce
Like
reply
Reply
share
Share

480 CE Auropharma open low same 9.75 now 13
Looks like it can reverse
Like
reply
Reply (1)
share
Share
Latest replies
M PRICE PLOTTING @mpriceplotting
Yesterday 6:54 PM

WOW Auro Pharma 466 and 480 CE high 17 from 13.5

AUROPHARMA - chart - 396321

Like
reply
Reply
share
Share
Stock movers for the week: Bharti Airtel, Century Textiles, Bandhan Bank top the charts
The top gainers included Bandhan Bank, Vodafone Idea, GRUH Finance and Bharti Airtel while the top losers were Century Textiles, Aurobindo Pharma, Indiabulls Housing Finance and Edelweiss Financial Services.
Moneycontrol
Like
reply
Reply
share
Share

AUROPHARMA - chart - 395636
AUROPHARMA has closed below a weekly support level and expected to test 390 levels in coming week.
Like
reply
Reply
share
Share
Aurobindo Pharma hits 5-year low after promoters create pledge earlier this week
"Pledge creation - on shortfall of security for the existing loans due to fall in share price," the company reasoned in its BSE filing.
Moneycontrol
Like
reply
Reply
share
Share

auropharma positional short cmp 446.7 sl 503 target 137 good short near 500
Like
reply
Reply
share
Share

Sell auro pharma cash
250-252
Sl 254
Tgt 245/240
1
reply
Reply (4)
share
Share
Latest replies
DREAM BIG VIEW @dreambig
Oct 11 4:27 PM

Sl
DREAM BIG VIEW @dreambig
Oct 11 5:52 PM

445.2
After sl 😠
DREAM BIG VIEW @dreambig
Oct 11 5:52 PM

445.2
After sl 😠
DREAM BIG VIEW @dreambig
Oct 11 6:19 PM

441 omg

Nirmal Bang Recommendation on AUROPHARMA
Date: 10-Oct-19 Broker: Nirmal Bang Price @ Call: 474.3 Target: 761 Recommendation: BUY
Like
reply
Reply
share
Share

Reliance Securities Recommendation on AUROPHARMA
Date: 10-Oct-19 Broker: Reliance Securities Price @ Call: 474.3 Target: 575 Recommendation: BUY
Like
reply
Reply
share
Share

Sell auropharma cash
458.5-463.5
Sl 465
Tgt.454/450/445
Like
reply
Reply (2)
share
Share
Latest replies
DREAM BIG VIEW @dreambig
Oct 10 5:22 PM

459.2 to 457.2
DREAM BIG VIEW @dreambig
Oct 10 6:20 PM

Selll igl updates
458.5 to 465.25
Near tgt 465
2+ points dn
💸💸💸💸💸💸

AUROPHARMA - chart - 392699

Like
reply
Reply
share
Share
Intraday Cash Trades in AUROPHARMA
Sell@454 T-440 SL-462

AUROPHARMA - 392501

Like
reply
Reply
share
Share

Sell@454
T-440
SL-462
Like
reply
Reply
share
Share
SAFE PORTFOLIO in AUROPHARMA
Auropharma looks good near for 8-10-15₹ bounce ...

Made high 485 from 470
Like
reply
Reply (2)
share
Share
Latest replies
Sunil @sunilkakkad
Oct 10 2:54 AM

Good calls
SAFE PORTFOLIO @safe
Oct 10 2:55 AM

Thanks

Prabhudas Lilladher Recommendation on AUROPHARMA
Date: 09-Oct-19 Broker: Prabhudas Lilladher Price @ Call: 458.5 Target: 511 Recommendation: HOLD
Like
reply
Reply
share
Share

Auropharma looks good near for 8-10-15₹ bounce back from here as extremely oversold. SL-urs.
Like
reply
Reply
share
Share
Aurobindo Pharma receives 7 observations from USFDA; share up 5%
The United States Food and Drug Administration (USFDA) has concluded inspection of the manufacturing facility with 7 observations.
Moneycontrol
Like
reply
Reply
share
Share

Brokerages view on Aurobindo
Citi: Stock reaction is overdone though overhang to persist
Edel Obs look a little serious in nature
Emkay: Mkt seems to be pricing in the worst case
GS: Stock move is overdone
JPM: Risk-reward is among the most favorable
Like
reply
Reply
share
Share
Stocks in news: DHFL, Aurobindo Pharma, Tata Motors, Titan, TCS, NMDC, Minda Industries
DHFL | Aurobindo Pharma | SJVN | Tata Motors | Titan | TCS | NMDC and Minda Industries are among the stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share

AUROBINDO PHARMA OUTLOOK
INTRADAY 419 BEST BUY WILL TOUCH 500
FOR ONE WEEK TARGET 590
FOR ONE MONTH TARGET 640
Like
reply
Reply
share
Share

Brokerages view on Aurobindo
Citi: Stock reaction is overdone though overhang to persist
Edel Obs look a little serious in nature
Emkay: Mkt seems to be pricing in the worst case
GS: Stock move is overdone
JPM: Risk-reward is among the most favorable
Like
reply
Reply
share
Share

CITI on Aurobindo Pharma
Compliance Overhang on Unit VII, Stk Reaction Disproportionate, & likely more than prices in potential impact even if these escalate to a warning letter
BUY, TP Rs 860
However overhang will remain on stk in near term
Like
reply
Reply
share
Share

AUROPHARMA - 390025

Like
reply
Reply
share
Share

AURO PHARMA VERY STRONG SUPPORT NEAR 446 IF BREAK AND SUSTAIN BELOW 428-400-380 ZONE WILL SEEN
AURO PHARMA STRONG RESISTANCE NEAR 485 CLBS THEN 520-545
STAY CONNECTED WITH HIDDEN_GEM
Like
reply
Reply
share
Share

AUROPHARMA - chart - 389795
AUROPHARMA
Like
reply
Reply
share
Share
Trade Setup for Wednesday: Top 15 things to know before Opening Bell
According to the pivot charts, key support level for Nifty is placed at 11,081.47, followed by 11,036.53. If the index starts moving up, key resistance levels to watch out for are 11,202.57 and 11,278.73.
Moneycontrol
Like
reply
Reply
share
Share

AUROPHARMA - 389487
Auropharma Investment in on the way . Do refer chart for Numbers and Track us in Telegram for all live updates and
Nifty and Bank Nifty Magical Intra Numbers !
Like
reply
Reply
share
Share

AUROPHARMA - 389174

Like
reply
Reply
share
Share

AUROPHARMA - 389149

1
reply
Reply (2)
share
Share
Latest replies
Dhruv @DhruvMan
Oct 7 11:28 PM

Terrible fall today. Wonder if this will undo any damage. I had Auropharma in my portfolio. Took them out since it broke the resistance with such strong volumes.
Booked loss :(( Lets see if discipline was of any value.
Dhruv @DhruvMan
Oct 7 11:29 PM

I thought Auro was a good company, waiting to touch 800 again. Sad ending for me :((
Aurobindo Pharma gets 7 observations from USFDA for its Telangana unit
The company, however, did not provide any details about the observations made by the US regulator.
Moneycontrol
Like
reply
Reply
share
Share
BCatchs in AUROPHARMA
Aurobindo Updated Chart. View Intact for 450. ...

Today's Auropharma Low exactly 450
1
reply
Reply
share
Share

Buy auropharma above 476 sl 471
Target 480/483/487/495
Like
reply
Reply
share
Share
Calls Unlimited in AUROPHARMA
auro freee fall 615 TO 525 + 90000 NOT OUT CHA...

615 TO 462 + 153000
ANYBODY SOLD ON TOP
CHAPO INDIA CHAPO
Like
reply
Reply
share
Share

Sell auropharma cash
475-478
Sl 482
Tgt 470/465/460
Like
reply
Reply (4)
share
Share
Latest replies
DREAM BIG VIEW @dreambig
Oct 7 8:16 PM

Auropharma
475 to 46
8
7 points in few minutes
Tgt 1 dn 470
Near tgt 2- 465
💸💸💸💸💸💸
DREAM BIG VIEW @dreambig
Oct 7 8:35 PM

Look at auropharma guys
Super jackpot 🔥
475 to 463.3
Tgt 1- dn 470
Tgt 2- dn 465
Near final tgt 460
11.5+ points☀ in few times
💸💸💸💸💸💸💸
DREAM BIG VIEW @dreambig
Oct 7 8:41 PM

475 to 459
Final tgt 460 over achived
💸💸💸💸💸💸
DREAM BIG VIEW @dreambig
Oct 7 9:00 PM

Auropharma
451.1 🤑 from 475
Aurobindo Pharma tanks 19%, touches 5-year low
CNBC TV18 reported that the company's unit-7 was inspected from September 19-27 by USFDA, which issued seven observations, including failure to thoroughly review any unexplained discrepancy.
Moneycontrol
Like
reply
Reply
share
Share

AUROPHARMA - 388679
#AuroPharma
Can we see all PE ITM??
Like
reply
Reply (2)
share
Share
Latest replies
Chetan Patil @chetanpatil
Oct 7 7:49 PM

How to interpret this? Please help understand
Manush @Nifty50striker
Oct 7 8:22 PM

That was question and not any view.

STOCK UDPATE: SELL #AUROBINDO @ 559
SL 571 & hold it
Till now 470.30, yes.........👌💋✈️😍 90 Rs DOWN.
WHAT YOU WANT CRYING BABIES ??
isko bolte h💪100 sunnar ki ek #Kingresearch ki !
#Learn & then #Earn !!
AAp ko bhi hamare jaise calls nikalna h to
JOIN 14th OctOnline class
Like
reply
Reply (1)
share
Share
Latest replies
Dhruv @DhruvMan
Oct 7 7:46 PM

Oh, so you new US FDA warnings were coming! :)

buy aurobindo pharma at 473
SL 430
target open ( wait up to october 11th )
Like
reply
Reply
share
Share

AUROPHARMA - chart - 388609

1
reply
Reply (1)
share
Share
Latest replies

Missed Auro Pharma Alert
Full Weekly Positional Tgt completed today only
Sell zone 557 for t:547-536-524-513-501-490-479 low 473
Calls Unlimited in AUROPHARMA
auro freee fall 615 TO 525 + 90000 NOT OUT CHA...

615 TO 485 + 140,000
580 PE OF 12 NOW AT 95 + 83000
I BET
NO ONE CAN GIVE SUCH A ADVANCE CALL LIKE THIS..
CHAPO INDIA CHAPO
Like
reply
Reply
share
Share
BCatchs in AUROPHARMA
Auropharma breaks the supports @ 540. View Inta...

AUROPHARMA - 388585
Aurobindo Updated Chart. View Intact for 450. Hope 450 hold or else further bleeding..
1
reply
Reply (2)
share
Share
Latest replies
rajesh shetty @rajeshshetty
Oct 7 11:21 PM

how can i learn under ur guidance ..burned my hands in pms . washed out my entire capital . right with some small amount . pls guide me . thank u sir
rajesh shetty @rajeshshetty
Oct 7 11:28 PM

sir .. 9969170077 rajesh shetty ..i m new to this app ..so cannot use the interface properly . hope u got my message
Exclusive: Aurobindo Pharma promoters to fund Dr T Gurunath Reddy amid tussle over Continental Hospitals
The Aurobindo family will fund gastroenterologist Gurunath Reddy buy out stake held by IHH Healthcare, and ring-fence Continental Hospitals from other prospective buyers.
Moneycontrol
Like
reply
Reply
share
Share
D-Street Buzz: Nifty Pharma falls 2%; Glenmark, Auro Pharma, Piramal Enterprises, Lupin touch 52-week lows
Shares of Glenmark Pharmaceuticals fell after the US Food & Drug Administration issued a warning letter to the company's Baddi facility.
Moneycontrol
Like
reply
Reply
share
Share
Calls Unlimited in AUROPHARMA
auro freee fall 615 TO 625 + 90000 NOT OUT CHA...

auro freee fall
615 TO 525 + 90000 NOT OUT
CHAPO INDIA CHAPO
Like
reply
Reply
share
Share
Calls Unlimited in AUROPHARMA
auro 615 to 552 + 63000 auro pe of 580 from 12...

auro freee fall
615 TO 625 + 90000 NOT OUT
CHAPO INDIA CHAPO
Like
reply
Reply
share
Share

STOCK UDPATE: SELL #AUROBINDO AT 559
KEEP SL 571 & hold it
Till now 526.........Party to banti h !!!
Like
reply
Reply
share
Share
  • AUROPHARMA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization46,051.74
    Enterprise Value50,495.97
    Price to Earnings18.01
    Price to Book Value4.06
    Return on Capital Employed0.17
    Return on Equity0.18
    Face Value1
    Dividend Yield0.01
  • AUROPHARMA Share Price - Technicals

    keyboard_arrow_down
    AUROPHARMA - 52 Week High₹838
    AUROPHARMA - 52 Week Low₹435.35
  • AUROPHARMA - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    10-Oct-19Reliance SecuritiesBuy575
    10-Oct-19Nirmal BangBuy761
    9-Oct-19Prabhudas LilladherHold511
    19-Aug-19Axis DirectBuy662
    9-Aug-19Prabhudas LilladherBuy715
    View all AUROPHARMA - Share Targets - Broker Reports
  • AUROPHARMA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Oct 14441473.2440.2459.25
    Oct 11465466.1435.35438.95
    Oct 10474474436.65465.15
    Oct 9474.15485454.15474.4
    Oct 7560.55564.35450.35459.85
  • AUROPHARMA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹569.14
    30 Day Moving Average₹582.83
    50 Day Moving Average₹581.83
    100 Day Moving Average₹600.18
    200 Day Moving Average₹679.64
  • AUROPHARMA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue10,2709,607.050.07
    Operating Profit2,6702,373.950.12
    Profit Before Tax2,3432,178.570.08
    Net Income1,8131,706.760.06
  • AUROPHARMA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds11,3519,9830.14
    Total Liabilities6,7906,1970.1
    Total Assets18,14116,1800.12
  • AUROPHARMA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity9142,457.2-0.63
    Cash from Investing Activity-981-1,542.05-0.36
    Cash from Financing Activity440-1,328.99-1.33
    Net Cash Flow372-413.84-1.9
  • AUROPHARMA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.110.13
    Return on Equity0.180.2
    Return on Capital Employed0.170.19
  • AUROPHARMA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.27
    3 Year CAGR Growth in Operating Profit0.19
    3 Year CAGR Growth in EBIDTA0.19
    3 Year CAGR Growth in Net Income0.2
    3 Yr CAGR Growth - Diluted EPS-0.4
  • AUROPHARMA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.89
    5 Year CAGR Growth in Operating Profit1.79
    5 Year CAGR Growth in EBIDTA1.79
    5 Year CAGR Growth in Net Income2.66
    3 Yr CAGR Growth - Diluted EPS0.82
  • AUROPHARMA Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Yesterday 10:58 PM
    Aurobindo Pharma breaks 2-day losing run; jumps 5%
    Moneycontrol
    NewsBot
    Yesterday 9:23 PM
    Aurobindo Q2 PAT seen up 6% YoY to Rs. 675.1 cr: Emkay
    Moneycontrol
    NewsBot
    Oct 12 5:08 PM
    Stock movers for the week: Bharti Airtel, Century Textiles, Bandhan Bank top the charts
    Moneycontrol
    NewsBot
    Oct 11 9:13 PM
    Aurobindo Pharma hits 5-year low after promoters create pledge earlier this week
    Moneycontrol
    NewsBot
    Oct 9 3:08 PM
    Aurobindo Pharma receives 7 observations from USFDA; share up 5%
    Moneycontrol
    NewsBot
    Oct 9 1:58 PM
    Stocks in news: DHFL, Aurobindo Pharma, Tata Motors, Titan, TCS, NMDC, Minda Industries
    Moneycontrol
    NewsBot
    Oct 8 11:43 PM
    Trade Setup for Wednesday: Top 15 things to know before Opening Bell
    Moneycontrol
    NewsBot
    Oct 7 11:03 PM
    Aurobindo Pharma gets 7 observations from USFDA for its Telangana unit
    Moneycontrol
    NewsBot
    Oct 7 8:08 PM
    Aurobindo Pharma tanks 19%, touches 5-year low
    Moneycontrol
    NewsBot
    Oct 7 6:28 PM
    Exclusive: Aurobindo Pharma promoters to fund Dr T Gurunath Reddy amid tussle over Continental Hospitals
    Moneycontrol
  • AUROPHARMA - Related Communities

    keyboard_arrow_down
    IRCTC Sector: Miscellaneous
    Share and discuss algorithms, strateg...
    Place for new investors to ask questi...
    Help fellow traders de-stress by shar...
    Share and discuss strategies for tax ...
    Want to know more about an upcoming I...
    MCX:MENTHAOIL
    MCX:CPO
    Purpose: Pool and discuss ideas & sug...
    Sector: Index
  • AUROPHARMA - More Information

    keyboard_arrow_down

    Aurobindo Pharma Ltd:
    Aurobindo Pharma Limited is propagating its business in researching, developing, manufacturing, and selling of several pharmaceutical products in India. Producing a significant variation in oral and injectable generic formulations, and active pharmaceutical ingredients and manufacturing peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries.
    Along with providing custom research and producing services to biotech and pharmaceutical community the company is reigning over antibiotic, anti-retroviral, cardiovascular, central nervous system, gastroenterological, anti-diabetic, and anti-allergy areas. Besides that, the company is manufacturing proteins, vitamins, minerals, and supplements, sports drinks etc.
    The company is exporting its products to almost 150 countries, including the U.S. and Europe along with serving multinational companies. The company is amongst the largest producers of Ampicillin and Cloxacillin in India. Aurobindo Pharma Limited was established in 1986 as a private limited company and headquartered in Hyderabad, Andhra Pradesh, India.
    About Company Information:
    Aurobindo Pharma was converted to a public limited firm in the year of 1992, after six years from its inception. The company built A CMIC chloride manufacturing unit at Pashamylaram near Hyderabad in the same year. The company started to issue bonus shares in a ratio of 1:1, 2:1 and 7:20 in ’92, ’93 and ’94 respectively. In 1993 the company built up another two plants at Bollaram and Kukatpally near Hyderabad. In 1994, the company increased the capacity at Pondicherry Unit from 204 TPA to 300 TPA along with increasing the installed capacity of its Bollaram unit from 78 TPA to 84 TPA. An amalgamation took place between the company and Chaitanya Organics Pvt. Ltd. in April 1994.
    Glaxo (India), a subsidiary of the U.K. based multinational Glaxo went for an alliance with Aurobindo Pharma in 1997, which increased the number of capsules and bulk drug up to 300 million and 840 tons respectively. In 1998, the company introduced Auronim Suspension in its pediatric segment. In FY 1999-2000, the company added a large section of Cephalosporins (Oral & Sterile) and anti-viral along with macrolides, quinolones, semi-synthetic penicillin, formulating for both the domestic and export market.
    During 2001-02 79% stake in Ranit Pharma Company were acquired by Aurobindo Pharma Ltd. A 50:50 joint venture firm of the company, namely Citadel Aurobindo Biotech Ltd, launched Aztreonam, a Monabactam Beta-lactam antibiotics as a debut in the Indian Pharma Market, TREONAM being the brand name, in 2003. In 2005-06, the company intervened in the markets of USA & Europe, with participation in the PEPFAR program, initiated by the US Govt. In March 2007, the FDA (U.S.) finally approved the company’s Didanosine Oral Suspension (Pediatric Powder) 10 mg/ml.
    Aurobindo Pharma acquired Moore and Carmiooro, the high profile OTC brands from TAD in 2008. AstraZeneca, a leading biopharmaceutical company in the international market, had gone for an agreement with Aurobindo Pharma, for supplying solid dosage and sterile products in 2010. A deal took place between Aurobindo Pharma and National Pharmaceutical Group Corporation, China, for launching the subsidiary Aurobindo (Datong) BioPharma Co Ltd, China (ADBPL).
    In April 2014, Aurobindo Pharma declared the completion of several business operations of Europe’s Actavis plc, an internationally recognized pharmaceutical company, manufacturing and supplying generic, brand and biosimilar products. On November 2016, a subsidiary of Aurobindo Pharma Ltd in France, namely Arrow Generiques SAS, signed an agreement to gain the right, title and interest in its products Calcium and Calcium Vitamin D3 in the French market, including the use of Teva Pharmaceutical Industries OROCAL trademark.
    On January 2017, Aurobindo Pharma declared about setting up a binding agreement by and through its solely owned subsidiary, Agile Pharma B.V., Netherlands, for acquiring Generis Farmaceutica SA, a pharmaceutical company of Portugal, against a lump sum of 135 million Euro totally including net working capital of 21.7 million Euro. On February 2017, four-cell culture derived biosimilar products from T.L. Biopharmaceutical AG were acquired by Aurobindo Pharma as declared by the company.
    How Aurobindo Pharma Ltd, is categorised as a Pharmaceutical and Healthcare Sector, and Pharmaceutical Industry :
    The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
    Aurobindo Pharma Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Aurobindo Pharma Ltd, Competitors and Sector Peers:
    Aarey Drugs & Pharmaceuticals Ltd. AARDRU
    Aarti Drugs Ltd. AARTDR
    Aayush Food & Herbs Ltd. AAYFOO
    Abbott India Ltd. ABBIND
    ABL Bio-Technologies Ltd. ABLBIO
    Addlife Pharma Ltd. ADDPHA
    Bacil Pharma Ltd. BACPHA
    Bafna Pharmaceuticals Ltd. BAFPHA
    Bajaj Healthcare Ltd. BAJHEA
    Brooks Laboratories Ltd. BROLAB
    Cipla Ltd. CIPLTD
    Dishman Pharmaceuticals & Chemicals Ltd.[Merged] DISPHA
    Divi's Laboratories Ltd. DIVIL
    Dr. Reddy's Laboratories Ltd. DR
    Dujohn Laboratories Ltd. DUJLAB
    Earum Pharmaceuticals Ltd.
    Elder Health Care Ltd. ELDHEA
    Elder Pharmaceuticals Ltd. ELDPHA
    Elegant Pharmaceuticals Ltd. ELEPHA
    Gennex Laboratories Ltd. GENLAB
    Genomics Biotech Ltd. GENBIO
    GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
    Glenmark Pharmaceuticals Ltd. GLEPHL
    IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
    JK Pharmachem Ltd. JKPHAL
    Jubilant Life Sciences Ltd. JUBILO
    Jupiter Bioscience Ltd. JUPIBI
    Lupin Ltd. LUPLTD
    Lyka Labs Ltd. LYKLAB
    Novartis India Ltd. NOVAIN
    Ortin Laboratories Ltd. ORTLAB
    Piramal Enterprises Ltd. NICPIR
    Piramal Phytocare Ltd. PIRLIF
    Ranbaxy Laboratories Ltd. RANLAB
    Sanjivani paranteral Ltd. SANPAR
    Sanofi India Ltd. AVEPHA
    Sarvodaya Labs Ltd. SARLAB
    Sun Pharmaceutical Industries Ltd. SUN28
    TTK Healthcare Ltd. TTKHEA
    Venmax Drugs & Pharmaceuticals Ltd. YENDRU
    Venus Remedies Ltd. VENREM
    Zenith Healthcare Ltd. ZENHEA
    Zenlabs Ethica Ltd. SHRLAK
    Zenotech Laboratories Ltd. ZENLAB
    Zim Laboratories Ltd. ZIMLAB
    Zora Pharma Ltd.[Amalgamated] ZORPHA
    Zota Healthcare Ltd. ZOTHEA
    Zyden Gentec Ltd. ZYDGEN
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.